| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 19, 2005
Accepted on March 16, 2006
Research Centre for Reproductive Health, Discipline of Obstetrics and Gynaecology, University of Adelaide, Adelaide, South Australia, Australia, 5005
* To whom correspondence should be addressed. E-mail: claire.roberts{at}adelaide.edu.au.
The placenta transports substrates and wastes between the maternal and fetal circulations. In mice, placental insulin-like growth factor (IGF)-II is essential for normal placental development and function but in other mammalian species maternal circulating IGF-II is substantial and may contribute. Maternal circulating IGFs increase in early pregnancy and early treatment of guinea pigs with either IGF-I or IGF-II increases placental and fetal weights by mid-gestation. We now show that these effects persist to enhance placental development and fetal growth and survival near term. Pregnant guinea pigs were infused with IGF-I, IGF-II (both 1 mg/kg/day) or vehicle subcutaneously from days 20 to 38 of pregnancy and killed on day 62 (term=69 days). IGF-II, but not IGF-I, increased the mid-sagittal area and volume of placenta devoted to exchange by
30%, the total volume of trophoblast and maternal blood spaces within the placental exchange region (+29% and +46%, respectively) and the total surface area of placenta for exchange by 39%. Both IGFs reduced resorptions and IGF-II increased the number of viable fetuses by 26%. Both IGFs increased fetal weight by 11-17% and fetal circulating amino acid concentrations. IGF-I, but not IGF-II, reduced maternal adipose depot weights by
30%. In conclusion, increased maternal IGF-II abundance in early pregnancy promotes fetal growth and viability near term by increasing placental structural and functional capacity, while IGF-I appears to divert nutrients from the mother to the conceptus. This suggests major and complementary roles in placental and fetal growth for increased circulating IGFs in early to mid pregnancy.
This article has been cited by other articles:
![]() |
K. Forbes, M. Westwood, P. N. Baker, and J. D. Aplin Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1313 - C1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Carter Maintaining the integrity of trophoblast during growth of the placenta. Focus on "Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta" Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1303 - C1304. [Full Text] [PDF] |
||||
![]() |
C.-H. Chu, B.-S. Tzang, L.-M. Chen, C.-H. Kuo, Y.-C. Cheng, L.-Y. Chen, F.-J. Tsai, C.-H. Tsai, W.-W. Kuo, and C.-Y. Huang IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via G{alpha}q interaction and protein kinase C-{alpha}/CaMKII activation in H9c2 cardiomyoblast cells J. Endocrinol., May 1, 2008; 197(2): 381 - 390. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Qiu, J.-Y. Jiang, M. Bell, B. K. Tsang, and A. Gruslin Activation of Endoproteolytic Processing of Insulin-Like Growth Factor-II in Fetal, Early Postnatal, and Pregnant Rats and Persistence of Circulating Levels in Postnatal Life Endocrinology, October 1, 2007; 148(10): 4803 - 4811. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Sferruzzi-Perri, J. A. Owens, P. Standen, R. L. Taylor, J. S. Robinson, and C. T. Roberts Early Pregnancy Maternal Endocrine Insulin-Like Growth Factor I Programs the Placenta for Increased Functional Capacity throughout Gestation Endocrinology, September 1, 2007; 148(9): 4362 - 4370. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Sferruzzi-Perri, J. A. Owens, P. Standen, R. L. Taylor, G. K. Heinemann, J. S. Robinson, and C. T. Roberts Early treatment of the pregnant guinea pig with IGFs promotes placental transport and nutrient partitioning near term Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E668 - E676. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |